OPIANT PHARMACEUTICALS INC's ticker is OPNT and the CUSIP is 683750103. A total of 10 filers reported holding OPIANT PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $198,000 | +7.0% | 15,100 | +17.6% | 0.01% | -30.8% |
| Q4 2018 | $185,000 | -5.1% | 12,835 | +17.0% | 0.01% | +18.2% |
| Q3 2018 | $195,000 | +2.1% | 10,968 | +9.7% | 0.01% | -8.3% |
| Q1 2018 | $191,000 | -59.2% | 10,000 | -51.0% | 0.01% | -52.0% |
| Q4 2017 | $468,000 | -8.4% | 20,400 | +46.8% | 0.02% | -7.4% |
| Q3 2017 | $511,000 | – | 13,900 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 357,960 | $5,173,000 | 4.54% |
| Granite Point Capital Management, L.P. | 75,000 | $1,084,000 | 0.22% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 99,874 | $1,444,000 | 0.11% |
| Eversept Partners, LP | 13,901 | $200,869 | 0.11% |
| BRASADA CAPITAL MANAGEMENT, LP | 20,400 | $295,000 | 0.10% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 24,197 | $350,000 | 0.02% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 24,373 | $352,000,000 | 0.01% |
| Spark Investment Management LLC | 12,835 | $185,000 | 0.01% |
| American Research & Management Co. | 300 | $4,000 | 0.00% |
| Advisor Group, Inc. | 4,700 | $69,000 | 0.00% |